Reported valuation; nothing comparable since.
- ·18 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Treeline Biosciences funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Later Stage VC | $200.1M | ▮ | ▮ |
| Oct 2024 | Later Stage VC | $421.8M | ▮ | ▮ |
Membership and data by Private Market View
Treeline Biosciences valuation
Treeline Biosciences is valued at approximately $1.3 billion as of Oct 2026. The figure is set by institutional fund marks.
Recent activity
In the last 90 days, Treeline Biosciences's record added 3 institutional fund marks (latest period Jul 2026).
How much has Treeline Biosciences raised?
Treeline Biosciences has raised $1.1 billion in total; 2 of its rounds are on record. The largest on record was a $422 million later-stage round in Oct 2024; the most recent was a $200 million later-stage round in Aug 2025.
Treeline Biosciences has filed 2 Form Ds with the SEC since 2024, most recently in Sep 2025 ($200 million sold to 22 investors).
Institutional holders and vehicles
2 SEC-registered funds reported 18 fair-value marks on Treeline Biosciences between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Treeline Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Treeline Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Treeline Biosciences
- What is Treeline Biosciences worth?
- Treeline Biosciences is valued at $1.3B as of Oct 2026. Reported valuation; nothing comparable since.
- How much has Treeline Biosciences raised?
- Treeline Biosciences has raised $1.1B in total funding across 2 recorded rounds.
- When did Treeline Biosciences last raise?
- Treeline Biosciences last raised in Aug 2025 (Later Stage VC), raising $200.1M.